Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Were

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Infection and Immunity|June 17, 2009
Suppression of a novel hematopoietic mediator in children with severe malarial anemiaChristopher C Keller, Collins Ouma, Yamo Ouma, et al.
BMC Infectious Diseases|June 26, 2012
Factors associated with non-adherence to Artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of western KenyaElizabeth O Onyango, George Ayodo, Carren A Watsierah, et al.
AIDS Research and Therapy|August 18, 2015
HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug usersValentine Budambula, Francis O Musumba, Mark K Webale, et al.
The Journal of Infectious Diseases|July 14, 2009
MIF (macrophage migration inhibitory factor) promoter polymorphisms and susceptibility to severe malarial anemiaGordon A Awandare, Jeremy J Martinson, Tom Were, et al.
AIDS (London, England)|March 3, 2006
Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malariaRichard O Otieno, Collins Ouma, John M Ong'echa, et al.
Infection and Immunity|October 25, 2006
Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemiaGordon A Awandare, Yamo Ouma, Collins Ouma, et al.
Clinical Immunology (Orlando, Fla.)|October 20, 2007
Increased circulating interleukin (IL)-23 in children with malarial anemia: in vivo and in vitro relationship with co-regulatory cytokines IL-12 and IL-10John M Ong'echa, Allison M Remo, Jan Kristoff, et al.
The Journal of Infectious Diseases|September 11, 2008
Polymorphic variability in the interleukin (IL)-1beta promoter conditions susceptibility to severe malarial anemia and functional changes in IL-1beta productionCollins Ouma, Gregory C Davenport, Gordon A Awandare, et al.
American Journal of Hematology|June 26, 2012
Reduced systemic bicyclo-prostaglandin-E2 and cyclooxygenase-2 gene expression are associated with inefficient erythropoiesis and enhanced uptake of monocytic hemozoin in children with severe malarial anemiaSamuel B Anyona, Prakasha Kempaiah, Evans Raballah, et al.
BMC Genetics|August 9, 2011
Polymorphic variability in the 3' untranslated region (UTR) of IL12B is associated with susceptibility to severe anaemia in Kenyan children with acute Plasmodium falciparum malariaJohn M Ong'echa, Evans O Raballah, Prakasha M Kempaiah, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Infection and Immunity|June 17, 2009
Suppression of a novel hematopoietic mediator in children with severe malarial anemiaChristopher C Keller, Collins Ouma, Yamo Ouma, et al.
BMC Infectious Diseases|June 26, 2012
Factors associated with non-adherence to Artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of western KenyaElizabeth O Onyango, George Ayodo, Carren A Watsierah, et al.
AIDS Research and Therapy|August 18, 2015
HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug usersValentine Budambula, Francis O Musumba, Mark K Webale, et al.
The Journal of Infectious Diseases|July 14, 2009
MIF (macrophage migration inhibitory factor) promoter polymorphisms and susceptibility to severe malarial anemiaGordon A Awandare, Jeremy J Martinson, Tom Were, et al.
AIDS (London, England)|March 3, 2006
Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malariaRichard O Otieno, Collins Ouma, John M Ong'echa, et al.
Infection and Immunity|October 25, 2006
Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemiaGordon A Awandare, Yamo Ouma, Collins Ouma, et al.
Clinical Immunology (Orlando, Fla.)|October 20, 2007
Increased circulating interleukin (IL)-23 in children with malarial anemia: in vivo and in vitro relationship with co-regulatory cytokines IL-12 and IL-10John M Ong'echa, Allison M Remo, Jan Kristoff, et al.
The Journal of Infectious Diseases|September 11, 2008
Polymorphic variability in the interleukin (IL)-1beta promoter conditions susceptibility to severe malarial anemia and functional changes in IL-1beta productionCollins Ouma, Gregory C Davenport, Gordon A Awandare, et al.
American Journal of Hematology|June 26, 2012
Reduced systemic bicyclo-prostaglandin-E2 and cyclooxygenase-2 gene expression are associated with inefficient erythropoiesis and enhanced uptake of monocytic hemozoin in children with severe malarial anemiaSamuel B Anyona, Prakasha Kempaiah, Evans Raballah, et al.
BMC Genetics|August 9, 2011
Polymorphic variability in the 3' untranslated region (UTR) of IL12B is associated with susceptibility to severe anaemia in Kenyan children with acute Plasmodium falciparum malariaJohn M Ong'echa, Evans O Raballah, Prakasha M Kempaiah, et al.
Pageof 5